Back to Search
Start Over
Five commercially-available antibodies react differentially with allelic forms of human HLA-DR beta chain.
- Source :
-
Molecular Immunology . Dec2022, Vol. 152, p106-110. 5p. - Publication Year :
- 2022
-
Abstract
- Allelic variants of HLA-DRB1 have been associated with a variety of autoimmune and infectious diseases. Although the precise molecular mechanisms by which HLA-DRB1 alleles predispose to a particular disease are currently unclear, it has been shown that mRNA expression levels of HLA-DRB1 are dependent on the different alleles. We aimed to measure HLA-DR beta chain levels in peripheral blood mononuclear cells of individuals carrying HLA-DRB1 *03:01/*04:01 and HLA-DRB1 *03:01/*15:01 alleles by western blotting, using five commercially-available HLA-DRB antibodies. We observed highly heterogeneous binding of the tested antibodies to the different allelic forms of the HLA-DR beta chain. Overall, we show that current immunological research that employs available antibodies to detect HLA-DR beta chains is biased towards detection of specific variants of the protein; this may cause significant discrepancy in quantification of protein expression in a heterogeneous human population. • RNA expression levels of HLA-DRB1 are dependent on the different HLA-DRB1 alleles. • Tested commercial HLA-DRB antibodies detect particular allelic forms of HLA-DRB1. • Novel tools are needed to study allele-specific protein expression of HLA-DRB1. [ABSTRACT FROM AUTHOR]
- Subjects :
- *HLA-DR antigens
*GENE expression
*MONONUCLEAR leukocytes
*IMMUNOGLOBULINS
Subjects
Details
- Language :
- English
- ISSN :
- 01615890
- Volume :
- 152
- Database :
- Academic Search Index
- Journal :
- Molecular Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 160335860
- Full Text :
- https://doi.org/10.1016/j.molimm.2022.10.008